David Shugarts

Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients

Daniel R. Kuritzkes, Joseph Quinn, Sharon L. Benoit et al. · AIDS · 1996 · 179 citations

Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial

Susan E. Krown, Carlee Moser, Patrick MacPhail et al. · The Lancet · 2020 · 87 citations · Full text

Treatment And Prevention, Resource-limited Settings, Pathology +3

Optimization of storage and shipment of cryopreserved peripheral blood mononuclear cells from HIV-infected and uninfected individuals for ELISPOT assays

Adriana Weinberg, Lin Song, Cindy Wilkening et al. · Journal of Immunological Methods · 2010 · 67 citations · Full text

Medicine, Human Retrovirus, Immunology +12

Resistance Mutations in Protease and Reverse Transcriptase Genes of Human Immunodeficiency Virus Type 1 Isolates from Patients with Combination Antiretroviral Therapy Failure

Benjamin Young, Steven C. Johnson, Minoo Bahktiari et al. · The Journal of Infectious Diseases · 1998 · 56 citations · Full text

Immunology, Pathology, Antiviral Drug +17

Emergence of Dual Resistance to Zidovudine and Lamivudine in HIV-1–Infected Patients Treated With Zidovudine Plus Lamivudine as Initial Therapy

Daniel R. Kuritzkes, David Shugarts, Minoo Bakhtiari et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2000 · 40 citations

Human Retrovirus, Pharmacology, Immunology +14